FDA expands scope of off-label guidance to include presentations from reprints
Regulatory NewsJoanne S. Eglovitch.jpg?lang=en-us&ext=.jpg)
Advertising, Promotion and LabelingComplianceMedical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/PolicyRegulatory NewsJoanne S. EglovitchAdvertising, Promotion and LabelingComplianceMedical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/Policy